Scientists identify new treatment for Activated PI3-kinase Delta Syndrome
Scientists have identified a new treatment approach for patients with a rare inherited immune disorder...
List view / Grid view
Scientists have identified a new treatment approach for patients with a rare inherited immune disorder...
Charles River Laboratories International, Inc. announced that its team of neuroscience drug discovery experts is presenting 27 scientific posters, both independently and collaboratively with clients, at Neuroscience 2017, the 47th annual meeting of the Society for Neuroscience (SfN).
Three-step pretargeted radioimmunotherapy offers safe and effective treatment for colorectal cancer...
Researchers have shown that starving a childhood brain tumour of the amino acid glutamine may improve the effect of chemotherapy...
Partnership with InSphero provides additional 3D solutions...
Researchers have discovered a new potential therapeutic target – located in the ribosome – to combat trypanosomes parasites...
Direct application of immune cells speeds and improves healing of acute and chronic wounds in animal models...
Brain changes linked to memory loss may provide a new focus for exploring ways to treat or prevent dementia...
Scientists have developed 'intelligent' nanoparticles which heat up to a temperature high enough to kill cancerous cells...
NatD, which mediates N-alpha-terminal acetylation of histone H4, found to promote lung cancer progression...
Blocking the action of two pro-inflammatory molecules can significantly reduce the symptoms of allergic asthma...
28 September 2017 | By Charles River
During this peer panel discussion, team members from Charles River discussed their views and strategies on Drug Discovery...
In this whitepaper, IntelliCyt Corporation describe how the iQue Screener is used to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens...
Researchers have identified that the presence of ApoE4 exacerbates the brain damage caused by toxic tangles of tau protein...
Depletion of B cells in the tumour micro-environment shows anti-tumour activity in patients with advanced metastatic melanoma...